This study tested a new COVID-19 booster vaccine designed to protect against newer virus variants like Omicron. It involved 46 generally healthy adults who had already received their primary COVID-19 vaccinations. Researchers gave participants a single booster shot to check if it…
Phase: PHASE1, PHASE2 • Sponsor: Entos Pharmaceuticals Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:35 UTC